NCT04503265 A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies Status RECRUITING Phase PHASE1/PHASE2
NCT04498767 Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) Status RECRUITING Phase NA
NCT04484636 PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study) Status COMPLETED Phase NA
NCT04477343 A Study to Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma Status RECRUITING Phase PHASE1
NCT04469504 Preoperative Prehabilitation for Sarcopenic Patients Prior to Pancreatic Surgery for Cancer Status RECRUITING Phase NA
NCT04464967 Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers Status WITHDRAWN Phase PHASE1/PHASE2
NCT04452357 Pulse-low-dose Rate (PLDR) Radiation in Pancreatic Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT04449289 Influence of Local Anesthetic Administration on the Cancer Recurrence Rate After Pancreatic Oncologic Surgery Status UNKNOWN Phase PHASE2
NCT04447092 Pembrolizumab Plus Chemotherapy in 1st Line Treatment of Pancreatic Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04440800 Feasibility of Wearable Activity Trackers for Detection of TOXicity in People Receiving Systemic Anticancer Treatment Status UNKNOWN Phase N/A
NCT04431258 ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study Status COMPLETED Phase PHASE1/PHASE2
NCT04431076 Patient Reported Outcomes Measures to Predict Pancreatic Surgery Outcomes Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04430842 Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S Status COMPLETED Phase PHASE1
NCT04427761 A Study of the Life Changes Experienced by Patients With Pancreatic Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04426669 A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering Status COMPLETED Phase PHASE1/PHASE2
NCT04425876 A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Resectable Pancreatic Cancer Status UNKNOWN Phase PHASE1
NCT04421820 BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours Status RECRUITING Phase PHASE1/PHASE2
NCT04420130 A Trial of Camrelizumab Combined With Ablation and Chemotherapy in Patients With Pancreatic Cancer Liver Metastasis(SHR-1210-HLJ-009) Status WITHDRAWN Phase NA